Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Kirk Randal J
Relationship:   10% Owner
City:   Radford
State:   VA
   
Insider Summary:
  
   
Companies Owned :   6    
Direct Shares   3,684,697    

Indirect Shares

   67,796,291      
Direct Value   $162,038,028    

Indirect Value

   $374,282,250      
Total Shares   71,480,988      
Total Value   $536,320,277      


Halozyme Therapeutics Inc $162,017,406 Alaunos Therapeutics $20,621 Halozyme Therapeutics Inc $162,017,406 Alaunos Therapeutics $20,621
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    14   
    0    

     Stock price went up :
    6   
    0    
     Stock price went down :
    8   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
   46.5%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Clinical Data Inc CLDA Director, 10% Owner 2011-04-12 0 2011-04-12 0    Premium*  
            Halozyme Therapeutics Inc HALO 10% Owner 2018-08-28 3,562,388 2018-08-28 6,629,464    Premium*  
            Precipio Inc PRPO 10% Owner 2012-02-03 0 2018-08-28 27,151    Premium*  
            Precigen Inc PGEN 0 2024-05-02 51,557,665    Premium*  
            Alaunos Therapeutics TCRT Director, 10% Owner 2015-12-31 122,309 2015-12-31 9,570,094    Premium*  
            Aquabounty Technologies, Inc. AQB 10% Owner 2020-02-13 0 2020-12-17 11,917    Premium*  
* Premium Members only  

Records found :    271         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 5 of 11
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
PGEN Precigen Inc Director   –       •       •   2022-02-22 4 A $2.03 $100,000 I/I 49,261 19,004,634 0 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2017-04-28 4 A $19.67 $999,979 I/I 50,267 5,335,131 0 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2018-04-30 4 A $18.18 $999,984 I/I 51,775 14,788,996 0 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2017-09-29 4 A $19.01 $999,966 I/I 51,820 13,481,970 0 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2017-08-31 4 A $18.63 $999,974 I/I 53,077 13,471,450 0 -
HALO Halozyme Therapeutics Inc 10% Owner   –       –       •   2006-12-05 4 B $2.84 $151,940 I/I 53,500 845,800 1.5 -
HALO Halozyme Therapeutics Inc 10% Owner   –       –       •   2018-06-27 4 S $17.34 $927,777 I/I (53,505) 3,945,650 0 -
PGEN Precigen Inc Director   –       •       •   2021-09-24 4 OE $0.00 $0 I/I 53,571 18,738,124 0 -
HALO Halozyme Therapeutics Inc Director   –       •       •   2011-11-22 4 B $8.11 $447,234 I/I 55,146 1,749,847 2.25 -
HALO Halozyme Therapeutics Inc Director   –       •       •   2011-11-21 4 B $8.04 $454,075 I/I 56,477 1,694,701 2.25 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2017-10-31 4 A $16.35 $999,991 I/I 56,701 13,494,202 0 -
HALO Halozyme Therapeutics Inc Director   –       •       •   2008-06-12 4 B $5.42 $308,940 I/I 57,000 172,439 2.25 -
HALO Halozyme Therapeutics Inc Director   –       •       •   2008-06-19 4 B $6.02 $360,598 I/I 59,900 382,691 2.25 -
HALO Halozyme Therapeutics Inc 10% Owner   –       –       •   2006-08-28 4 B $2.56 $153,600 I/I 60,000 475,300 1.5 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2019-05-21 4 B $4.74 $285,457 I/I 60,223 930,504 2.64 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2019-05-17 4 B $4.69 $283,886 I/I 60,530 858,125 2.64 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2018-03-30 4 A $15.33 $999,979 I/I 60,551 14,777,995 0 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2018-05-31 4 A $16.20 $999,976 I/I 61,444 14,801,058 0 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2018-06-29 4 A $13.94 $999,987 I/I 63,882 14,815,405 0 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2018-07-31 4 A $14.66 $999,982 I/I 65,657 15,950,961 0 -
HALO Halozyme Therapeutics Inc Director   –       •       •   2007-09-13 4 B $8.74 $574,332 I/I 65,713 3,565,713 2.25 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2018-09-28 4 A $14.31 $999,979 I/I 67,518 15,975,578 0 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2019-06-04 4 B $5.17 $349,900 I/I 67,679 154,803 2.64 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2018-01-31 4 A $13.00 $999,981 I/I 69,768 14,749,589 0 -
PGEN Precigen Inc   –       •       •   2024-03-14 4 A $1.43 $100,000 I/I 69,930 32,121,391 0 -
  271  Records found
  1   2   3   4   5  6   7   8   9   10   11      
  Page 5 of 11  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us